We have cloned and sequenced the structural genes encoding the ⌬ 5,6 sterol desaturase (ERG3 gene) and the 14␣-methyl sterol demethylase (ERG11 gene) from Candida glabrata L5 (leu2). Single and double mutants of these genes were created by gene deletion. The phenotypes of these mutants, including sterol profiles, aerobic viabilities, antifungal susceptibilities, and generation times, were studied. Strain L5D (erg3⌬::LEU2) accumulated mainly ergosta-7,22-dien-3␤-ol, was aerobically viable, and remained susceptible to antifungal agents but had a slower generation time than its parent strain. L5LUD (LEU2 erg11⌬::URA3) strains required medium supplemented with ergosterol and an anaerobic environment for growth. A spontaneous aerobically viable mutant, L5LUD40R (LEU2 erg11⌬::URA3), obtained from L5LUD (LEU2 erg11⌬::URA3), was found to accumulate lanosterol and obtusifoliol, was resistant to azole antifungal agents, demonstrated some increase in resistance to amphotericin B, and exhibited a 1.86-fold increase in generation time in comparison with L5 (leu2). The double-deletion mutant L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) was aerobically viable, produced mainly 14␣-methyl fecosterol, and had the same antifungal susceptibility pattern as L5LUD40R (LEU2 erg11⌬::URA3), and its generation time was threefold greater than that of L5 (leu2). Northern (RNA) analysis revealed that the single-deletion mutants had a marked increase in message for the undeleted ERG3 and ERG11 genes. These results indicate that differences in antifungal susceptibilities and the restoration of aerobic viability exist between the C. glabrata ergosterol mutants created in this study and those sterol mutants with similar genetic lesions previously reported for Saccharomyces cerevisiae.
Candida glabrata is a pathogenic haploid yeast species which causes both mucocutaneous and deep infections in humans. The increasingly extensive use of topical and systemic antifungal drugs has increased the incidence of mucous-membrane colonization and infections with C. glabrata (35) and led to the appearance of azole-resistant infections with Candida species, including C. glabrata (22) .
The mechanism(s) by which Candida species become resistant to azole antifungal agents is poorly understood. While these agents adversely affect a number of cellular functions, their primary mechanism of action is the inhibition of cytochrome P-450-dependent lanosterol 14␣-demethylase (P-450 DM ), encoded by the ERG11 gene (15, 29, 31) . Postulated mechanisms of resistance include changes in cell permeability (11, 13) , overproduction or alteration of P-450 DM (3, 30) , and modification of other enzymes involved in sterol synthesis (10) . One such enzyme, the ⌬ 5,6 sterol desaturase, encoded by the ERG3 gene, has been associated with the development of resistance in two yeast species, Saccharomyces cerevisiae (16, 34) and Candida albicans (14) , which are closely related to C. glabrata.
Mutations or disruptions of ERG3 in S. cerevisiae result in the formation of ergosta-7,22-dien-3␤-ol as the major sterol (2) and are associated with increased resistance to azole and polyene antifungal agents (34) . Additionally, this gene has been implicated in the development of azole resistance because mutations of the ERG3 gene exert a suppressor effect on the phenotype of strains containing ERG11 mutations, allowing aerobic viability in the background of a normally lethal mutation (4, 16, 27) . S. cerevisiae strains which harbor lethal mutations in the ERG11 gene survive only in an anaerobic environment and require medium supplemented with ergosta-5,7,22-trien-3␤-ol (ergosterol) for growth. However, spontaneous aerobically viable mutants derived from these strains accumulate primarily 14␣-methylfecosterol and have been shown to carry a mutation in ERG3 (4) . The ERG3 defect in these double mutants has been postulated to maintain aerobic viability by blocking the accumulation of toxic 3␤,6␣-diol sterols formed by an active desaturase enzyme on 14␣-methylated sterols (33) . These diol sterols have been shown to accumulate in wild-type strains of S. cerevisiae treated with azole antifungal agents (33) and in a C. albicans strain lacking P-450 DM activity (4) .
Genetic studies of sterol biosynthesis in the pathogenic yeast C. albicans have been hindered by the organism's asexual diploid state. Mutations of genes involved in ergosterol biosynthesis have been inferred from sterol profile analyses of polyene-or azole-resistant strains without genetic confirmation. Current evidence suggests that lack of ⌬ 5,6 desaturase activity can lead to azole resistance, as in the clinically derived C. albicans Darlington strain. This azole-resistant strain produces ergosta-8,24(28)-dien-3␤-ol (fecosterol) as its major sterol and lesser but significant amounts of episterol (14) . Evidence that C. albicans strains considered to be erg11 mutants are aerobically viable in the absence of a suppressor mutation in the ERG3 gene has been obtained from polyene-resistant strains lacking P-450 DM activity. These strains accumulate substantial amounts of 14␣-methylated 3␤,6␣-diol sterols (4, 25) . Nevertheless, an association between the occurrence of mutations in the ERG3 and ERG11 genes has been detected in a C. albicans strain, KD4952. C. albicans KD4952 is an ergosterol mutant obtained as a hypha-forming revertant of the nystatin-resistant strain KD4950, which lacks P-450 DM activity. The sterol profile of KD4950 suggests that the strain has mutations in both the ERG11 and the ERG3 genes, while its revertant KD4952 accumulates primarily ergosta-7,22-dien-3␤-ol and is thought to retain only the ERG3 mutation (25, 26) . A comparison of in vitro triazole susceptibilities between KD4950, KD4952, and the wild-type KD14 has not been reported. Nystatin susceptibility of KD4952 is intermediate between those of KD4950 and KD14.
C. glabrata is a useful species for the study of sterol pathways and azole drug resistance because the fungus is haploid and because it is an important pathogen in its own right. We have cloned and sequenced the C. glabrata ERG3 and ERG11 genes and have deleted them alone and sequentially in the C. glabrata L5 (leu2) strain. Aerobic viability, sterol profiles, antifungal susceptibilities, and generation times of the deletion mutants were studied in order to better understand the sterol requirements and mechanism(s) of azole resistance of C. glabrata.
MATERIALS AND METHODS
Strains. The C. glabrata strains used in this study and their genotypes are listed in Table 1 . C. glabrata L5 (leu2) was kindly supplied by D. R. Winge (20) . Strain L5D (erg3⌬::LEU2) was created by disruption of the ERG3 gene in strain L5 (leu2). C. glabrata L5L (LEU2) was created by transformation of L5 (leu2) with the LEU2 gene of S. cerevisiae. The URA3 auxotrophs, L59D (erg3⌬::LEU2 ura3) and L59L (LEU2 ura3), were obtained by plating strains L5D (erg3⌬::LEU2) and L5L (LEU2) on 5-fluoro-orotic acid-containing media as previously described (5) . Strains L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) and L5LUD40 (LEU2 erg11 ⌬::URA3) were obtained by disrupting the ERG11 genes of L59D (erg3⌬::LEU2 ura3) and L59L (LEU2 ura3), respectively. Strain L5LUD40R (LEU2 erg11⌬::URA3) was a spontaneous aerobically viable mutant of L5LUD40 (LEU2 erg11⌬::URA3). S. cerevisiae genomic DNA was kindly supplied by A. Varma. Plasmid DNA was propagated in Escherichia coli DH10␤ (GibcoBRL, Gaithersburg, Md.) and E. coli XL1-blue cells (Stratagene, La Jolla, Calif.).
Media and growth. C. glabrata strains were maintained on 1% (wt/vol) yeast extract-2% (wt/vol) peptone-2% (wt/vol) dextrose (YEPD) media. Following transformation with the erg3⌬::LEU2 deletion construct, transformants were plated on yeast nitrogen base media with 2% (wt/vol) glucose (MING). Strains transformed with the erg11⌬::URA3 deletion construct were plated anaerobically on MING media supplemented with 35 g of ergosterol per ml and 0.0875% (vol/vol) Tween 80. E. coli strains were grown in Luria-Bertini broth or agar with 50 g of ampicillin per ml and 40 g of 5-bromo-4-chloro-3-indolyl-␤-D-galactoside (United States Biochemical Corp., Cleveland, Ohio) per ml. Except as noted, yeast strains were grown at 30ЊC and E. coli was grown at 37ЊC. For long-term storage, yeast strains were placed at Ϫ80ЊC in 20% glycerol.
Vectors and deletion constructs. C. glabrata ERG3 and ERG11 genes were cloned into the plasmids pBluescript SKII (pBSK; Stratagene), pUC19, and pSPORT 1 (GibcoBRL). Restriction maps of these clones and deletion constructs are depicted in Fig. 1 Generation times. Overnight cultures of C. glabrata strains were inoculated into 50 ml of YEPD in 250-ml flasks and shaken at 200 rpm at 30ЊC. Cultures were initially adjusted to an optical density of 0.05 at 600 nm in a DU-64 spectrophotometer (Beckman Instruments, Columbia, Md.), and generation times were calculated from absorbance spectra measured at 2, 4, 6, and 8 h. These studies were performed in triplicate, and results reflect the average for these studies.
Nucleic acid isolation and hybridization. DNA was isolated and Southern analysis was performed as previously described (8) . RNA was isolated from cells grown to mid-log phase, washed with 1 M sodium chloride, and resuspended in a lysis buffer (4% [wt/vol] sodium dodecyl sulfate, 0.15 M sodium acetate, and 0.05 M EDTA). An equal volume of 0.45-mm-diameter glass beads was added, and the cells were vortexed for a total of 3 min in 30-s intervals. The supernatant was removed and extracted three times with an equal volume of phenol-chloroform and a final time with chloroform. Northern (RNA) analysis was performed by standard procedures at high stringency (24) . Radiolabeled probes were prepared by using the Prime-It II kit (Stratagene) according to the instructions of the manufacturer.
DNA transformations. C. glabrata was transformed by electroporation as described by Varma et al. (32) . E. coli cells were transformed in a Gene Pulser (Bio-Rad Laboratories, Richmond, Calif.) according to the instructions of BioRad Laboratories.
PCR. PCRs were performed in a Perkin-Elmer Cetus DNA Thermal Cycler (Perkin-Elmer, Norwalk, Conn.) by using Taq DNA polymerase (Boehringer Mannheim Corporation, Indianapolis, Ind.). The oligonucleotides DSS1 and DSS2 (Table 2) , which contain sequences complementary to the published S. cerevisiae ERG3 sequence (2), were used to amplify a 1.083-kb DNA fragment from S. cerevisiae DNA. A 0.525-kb DNA fragment of the ERG11 gene was obtained with primers DMS1 and DMS2 (Table 2 ). Both fragments were used to probe C. glabrata Southern blots. C. glabrata transformants were screened for homologous integration and gene deletion by PCR analysis with oligonucleotides which were complementary to deleted DNA sequences. The ERG3 gene from strain L5LUD40R (LEU2 erg11⌬::URA3) was obtained by PCR with oligonucleotides complementary to sequences flanking the 3Ј and 5Ј regions of this gene.
A 0.83-kb DNA fragment of the C. albicans actin gene (19) was obtained by PCR with oligonucleotides ACT1 and ACT2 (Table 2) .
DNA sequencing. Plasmid DNA was sequenced by the dideoxy chain termination method according to the instructions provided with the Sequenase kit (United States Biochemicals). Sequence analysis was performed by using the Genetics Computer Sequence Analysis Software Package (7) in a Convex C240 computer maintained by the Division of Computer Research and Technology at the National Institutes of Health.
Cloning of the C. glabrata ERG3 and ERG11 genes. The 1.083-kb S. cerevisiae ERG3 fragment was used to probe a Southern blot of C. glabrata L5 (leu2) DNA digested with restriction endonucleases. On the basis of these results, a partial BglII-digested C. glabrata genomic DNA library containing fragments in the 3-to 4-kb range was constructed in pBSK. Following transformation into E. coli, clones were screened with the S. cerevisiae probe and further identified by sequence analysis. pCGDSB, obtained from this library, contained a 3.5-kb DNA fragment encoding part of the C. glabrata ERG3 open reading frame (ORF), all except for 331 bp of the 3Ј-end sequence. To obtain a complete C. glabrata ERG3 gene, pCGDSB was used to probe a partial DNA library containing XhoI-PstI fragments in the 3-to 5-kb range. pCGDS-3P, a 3.2-kb DNA fragment ligated into pBSK, was obtained from this library. The two clones were ligated together with overlapping sequences deleted to obtain pCGDL5 ( Fig. 1) .
The C. glabrata ERG11 gene was obtained in the manner described above. The 0.525-kb S. cerevisiae ERG11 DNA fragment was used to probe a C. glabrata Southern blot. A partial genomic library containing 5-to 8-kb HindIII DNA fragments was screened. pDM1, a clone isolated from this library, contained a 6.5-kb DNA fragment encoding most of the C. glabrata ERG11 sequences. The missing 5Ј sequences were obtained by screening a PstI-BamHI genomic library composed of 2-to 3-kb DNA fragments ligated into pBSK. pDM2, a clone with a 2.7-kb insert encoding 187 bp of the 5Ј end of the ERG11 ORF and 5Ј flanking sequences, was selected. pDM1 and pDM2 inserts were ligated together in pSPORT 1 to obtain pDM3 as depicted in Fig. 2 .
The deletion constructs for the ERG3 gene, pCGDL7, and the ERG11 gene, pDM4, were obtained as illustrated in Fig. 1 and 2 .
Transformation of C. glabrata L5 to leucine prototrophy. C. glabrata L5 (leu2) was transformed with SmaI-digested pCGLEU and grown on minimal media without leucine; transformants were stable when maintained on YEPD. One of these transformants, C. glabrata L5L (LEU2), was used as a control in the analysis of the ERG3 deletion mutants.
Gene disruption. Disruption of the ERG3 gene was accomplished by transforming C. glabrata L5 (leu2) with a linear SmaI-PstI fragment from pCGDL7. The linearized deletion construct was not further purified from the remainder of the vector. Transformants were grown aerobically at 30ЊC. Disruption of the ERG11 gene was achieved by transforming strains L59L (LEU2 ura3) and L59D (erg3⌬::LEU2 ura3) with AvrII-SpeI-digested pDM4. Transformants were grown anaerobically at 35ЊC, and transformants requiring an anaerobic environment were subsequently maintained in a GasPak Anaerobic system (Becton Dickinson Microbiology Systems, Cockeysville, Md.). Antifungal susceptibility. In vitro testing for susceptibilities to the triazole antifungal agents fluconazole (Pfizer, Central Research, Sandwich, United Kingdom) and itraconazole (Janssen Research Foundation, Beerse, Belgium) and the polyene antifungal agent amphotericin B (Bristol-Myers Squibb, Princeton, N.J.) was performed in microtiter plates. Antifungal agents were dissolved in dimethyl sulfoxide (Sigma Chemical Company, St. Louis, Mo.), and stock solutions were stored at Ϫ80ЊC. Dilutions of the drugs were made in RPMI 1640 with Lglutamine and 0.165 M MOPS (morpholinepropanesulfonic acid), without sodium bicarbonate, with 20 g of glucose per liter and with the pH adjusted to 7. Samples (100 l) of the final drug dilutions were added to the microtiter plates. Yeast cells were plated on YEPD at 35ЊC overnight and resuspended in 0.85% (wt/vol) saline, and titers were adjusted spectrophotometrically. Further dilutions in RPMI 1640 were made, modified as described above. Inocula were verified by plating a dilution of the cells on YEPD agar and determining CFU per milliliter. Final inocula were in the range of 3 ϫ 10 4 to 5 ϫ 10 4 CFU/ml. Plates were incubated at 35ЊC and read at 24 and 48 h. Optical densities of 1:5 dilutions of the drug-free control well and drug-containing wells were read at 48 h in a Beckman DU spectrophotometer at 600 nm. At 48 h the amount of growth in each of the wells was measured by optical density. The MIC was defined as the concentration of drug which inhibited Ͼ75% of growth compared to the control well. These studies were performed with duplicate rows.
Sterol analysis. Nonsaponified lipids were extracted from late-exponentialphase cultures of C. glabrata L5 (leu2), L5D (erg3⌬::LEU2), L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3), L5LUD40R (LEU2 erg11⌬::URA3), and L5L (LEU2) as described previously for C. albicans (12) . The nonsaponifiable lipid fraction was dissolved in a small volume of chloroform-methanol (2:1, vol/vol) and loaded on silica-gel H preparative thin-layer chromatography plates (Merck). The nonsaponifiable lipid fraction was chromatographed with light petroleum (bp, 60 to 80ЊC)-diethyl ether-acetic acid (85:15:1, vol/vol) as the developing solvent. Lipids were detected under UV light at 350 nm, and the sterol fraction was identified by comparison of its R f value with that of an authentic ergosterol standard. The sterol fraction was eluted from the silica gel with chloroform-methanol (2:1, vol/vol), reduced to dryness under a stream of N 2 , and converted to trimethylsilyl (TMS) derivatives (6) . Sterol identification was made by gas chromatography (GC) and GC-mass spectrometry (GC-MS). For GC analyses, TMS-sterols were fractionated by using a Perkin-Elmer 8700 instrument equipped with a flame ionization detector and a Durabond DB5 fused silica capillary column (internal diameter, 0.3 mm), operated isothermally at 260ЊC. The injector and detector temperatures were 300ЊC, and the carrier gas was He. Sterols were identified by comparison of their retention times with those of authentic standards (ergosterol and 4,4,14␣-trimethylcholesta-8,24-dien-3␤-ol [lanosterol]), and 4,14␣-dimethylergosta-8,24-dien-3␤-ol (obtusifoliol), ergosta-7,22-dien-3␤-ol, 4,14-dimethylzymosterol, and fecosterol were extracted from polyene-resistant strains of C. albicans (ATCC 38245, 38246, and 38248). The   FIG. 1 . Vector pCGDSB contains a 3.5-kb BglII DNA fragment ligated into the pBSK BamHI site. pCGDL4 was made by subcloning a 2.7-kb SmaI-XbaI fragment from pCGDSB into pUC19. pCGDS-3P contains a 3.2-kb XhoI-PstI C. glabrata DNA fragment cloned into pBSK. The same fragment was subcloned into XbaI-PstIdigested pCGDL4 to create pCGDL5, producing a vector which contained the ERG3 ORF and ϳ2.5 kb of 5Ј and ϳ1.5 kb of 3Ј flanking sequences. pCGDL7 was made by deleting an ϳ1-kb XhoI-BglII fragment of the ERG3 gene and inserting a 2.6-kb XhoI-BglII DNA fragment of YEp13 containing the S. cerevisiae LEU2 gene. sterols were quantified by electronic integration of chromatogram peaks, and the results are expressed as percent area. For GC-MS analyses, TMS-sterols were fractionated by using a Fisons MD800 dedicated GC-MS instrument with a 25-m fused silica column (internal diameter, 0.25 mm) of CPSil-8CB (Chrompak). The oven temperature ramp was 200ЊC for 2 min, rising to 300ЊC at a rate of 20ЊC/min. Injection (1 l) was via a splitless injector (40:1) at 270ЊC, and the carrier gas was He. The MS electron energy was 70 eV, and the electron current was 100 A. Sterols were identified by comparison of their fragmentation data with those in reference databases (National Institute for Standards and Technology, Gaithersburg, Md.) and publications (14, 34) .
Nucleotide sequence accession numbers. The nucleotide sequence data reported in this paper have been submitted to the Genome Sequence Data Base. The nucleotide sequence accession number for the C. glabrata ERG3 gene is L40390. The accession number for the nucleotide sequence of the C. glabrata ERG11 gene is L40389.
RESULTS
Sequence analysis of the C. glabrata ERG3 gene. The sequence of the C. glabrata ERG3 gene and its nearby flanking sequence is shown in Fig. 3 . An ORF beginning with the ATG codon at position ϩ1 extends 1,092 nucleotides and encodes 364 amino acids. The derived amino acid sequence of the product of the C. glabrata ERG3 gene and the sequence of the S. cerevisiae ERG3 gene product have a 71.6% identity. A hydrophobicity plot generated by the Kyte and Doolittle algorithm (17) identifies a 23-amino-acid segment with characteristics of transmembrane domains. The segment is located near the amino terminus, beginning with amino acid 97, and has a hydropathy value of 1.9. This sequence has 83% identity with a 24-amino-acid sequence in the S. cerevisiae protein which has an average hydrophobicity of 2.0 and begins at amino acid position 95. This area has been postulated to serve as a region which binds the protein to the endoplasmic reticulum (2) .
Analysis of the ERG3 gene sequence of L5LUD40R (LEU2 erg11⌬::URA3) did not reveal the presence of any mutations.
Sequence analysis of the C. glabrata ERG11 gene. The sequence of the C. glabrata ERG11 gene and nearby flanking sequences is shown in Fig. 4 . An ORF beginning with the ATG codon at position ϩ1 extends 1,599 nucleotides and encodes FIG. 2 . Vector pDM1 contains a 6.5-kb C. glabrata HindIII fragment cloned into pBSK. This fragment contains sequences which encode all but 183 bases of the 5Ј end of the ERG11 gene ORF as well as 3Ј flanking sequences. pDM2 is an ϳ2.7-kb DNA cloned into pSPORT 1. The fragment encodes the missing 5Ј region of the ERG11 ORF and 5Ј flanking sequences. The BamHI-BssHII fragment of pDM1 was ligated into BamHI-MluI-digested pDM2 to form pDM3. pDM3 was digested with BamHI-EcoRI and blunt ended. The S. cerevisiae URA3 gene, obtained as a 1.1-kb HindIII fragment from YEp24, was blunt ended and ligated into pDM3, forming the deletion construct pDM4.
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CANDIDA GLABRATA ERG3 AND ERG11 GENES 2711 533 amino acids. A second ATG codon is found in frame with this sequence starting at position 103. On the basis of sequence homology with the S. cerevisiae ERG11 gene, the first ATG codon would appear to represent the initiation codon. The derived amino acid sequence of the C. glabrata P-450 DM is more homologous to the sequence of S. cerevisiae (15) , with an 84.5% identity, than to that of C. albicans (18) , with which it has a 65% identity. S. cerevisiae P-450 DM contains a region near the amino terminus which is 20 amino acids in length, has a hydropathy value greater than 1.6, and is followed immediately by cationic residues. These features are characteristic of membrane-anchoring peptides (23) . While the C. glabrata amino terminus is mostly hydrophobic, no region with the above-mentioned characteristics could be identified. The putative heme-binding domain, or HR2 region, of P-450 proteins (9) can be identified in the C. glabrata protein and surrounds the cysteine residue at position 465. The cysteine residue has been postulated to provide the proximal thiolate ligand to heme and is surrounded by a number of invariant residues, a phenylalanine at residue Ϫ7, and glycine at residues Ϫ4 and ϩ2 with respect to the cysteine. The HR2 regions of the C. glabrata and S. cerevisiae ERG11-derived proteins are 95% identical (15) . Deletion of the ERG3 gene. Twenty-four colonies of C. glabrata L5 (leu2) which were transformed with pCGDL7 were initially screened by PCR, with oligonucleotides CGDX2 and CGDX8 (Table 2) , to determine if homologous integration had taken place. Five of 24 transformants tested appeared to have undergone homologous integration with loss of the ORF. Gene deletion in one of these transformants, L5D (erg3 ⌬::LEU2), was confirmed by Southern blot analysis (Fig. 5) .
Deletion of the ERG11 gene. Following growth under anaerobic conditions, 29 of the L59L (LEU2 ura3) colonies transformed with the erg11 deletion construct were plated on MING (Table 2 ) were used to screen for homologous transformation. All colonies were found to contain the S. cerevisiae URA3 gene, indicating that transformation with pDM4 had occurred. The aerobically viable colonies contained the deleted sequences of the C. glabrata ERG11 deletion construct, demonstrating a lack of homologous integration in these colonies (data not shown). Deletion of the ERG11 gene in one of the aerobically nonviable colonies, L5LUD40 (LEU2 erg11 ⌬::URA3), was confirmed by Southern blot analysis (Fig. 6 ). When ERG11 deletion mutants were plated aerobically, spontaneous mutants which were aerobically viable were found to arise from a background lawn of colonies. An aerobically viable spontaneous mutant, L5LUD40R (LEU2 erg11⌬::URA3), recovered from strain L5LUD40 (LEU2 erg11⌬::URA3), was studied by Southern ( Fig. 6) and Northern (Fig. 7) blot analyses, and its sterol profile was determined. Transformants of the L59D (erg3⌬::LEU2 ura3) strain were initially plated on MING supplemented with ergosterol and Tween and grown in an anaerobic environment. Forty-seven of these were then plated aerobically and anaerobically, in the same manner as for the L59L (LEU2 ura3) transformants. While all were aerobically viable, approximately one-third of the transformants grew at a much slower rate than the others. PCR analysis confirmed that homologous integration and deletion of the ERG11 gene had taken place in these isolates (data not shown). Southern analysis confirmed deletion of the ERG11 gene in one of these, L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) (Fig. 6) .
Northern blot analysis. A Northern blot of whole-cell RNA extracted from C. glabrata L5 (leu2), L5D (erg3⌬::LEU2), L5L (LEU2), L5LUD40R (LEU2 erg11⌬::URA3), and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) was probed with a radiolabeled XhoI-NcoI DNA fragment of pCGDSB, which encodes the ERG3 ORF, and a DNA fragment of the ERG11 ORF obtained by PCR with oligonucleotides CGDM3 and CGDM13 (Table 2) . A fragment of the C. albicans actin gene was used as a control probe to quantify amounts of RNA. No ERG3 transcript can be detected in the ERG3 deletion mutants L5D FIG. 5 . Southern blot of EagI-digested DNA extracted from L5 (leu2), L5L (LEU2), and an ERG3 deletion mutant, L5D (erg3⌬::LEU2), probed with a 1.7-kb XhoI-NcoI DNA fragment of pCGDSB containing sequences 5Ј relative to the C. glabrata ERG3 gene. The probe hybridizes to a ϳ3.4-kb band in the L5 (leu2) and L5L (LEU2) lanes, whereas in the L5D (erg3⌬::LEU2) lane it hybridizes to a 5-kb band. The size difference is accounted for by the 1.6-kb difference in size between the deleted ERG3 sequences in L5D (erg3⌬::LEU2) and the sequences encoding the S. cerevisiae LEU2 gene which replaced them.
FIG. 6. Southern blot of
AvaI-digested DNA extracted from L5 (leu2), L5L (LEU2), L5D (erg3⌬::LEU2), L5LUD40 (LEU2 erg11⌬::URA3), L5LUD40R, and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3). The blot was probed with a 1.3-kb DNA fragment encoding sequences of the ERG11 ORF which were not deleted from pDM4 and of 3Ј flanking sequence. The probe was obtained with the oligonucleotides CGDM21 and CGDM3 ( Table 2 ). The probe hybridizes to an ϳ5.3-kb band in the first three lanes, which contain DNA from strains with intact ERG11 genes. In ERG11 deletion mutants, the probe hybridizes to a band of ϳ4 kb. AvaI restriction sites are found in the 3Ј and 5Ј flanking sequences of the ERG11 gene, but no sites are found within the ORF. In the deletion mutants, sequences from the ERG11 ORF have been replaced by the S. cerevisiae URA3 gene, which has one AvaI restriction site in its ORF. This accounts for the smaller band seen with ERG11 deletion mutants. DS) transcript is not detected in L5D (erg3⌬::LEU2) and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3), but the amount of ⌬ 5,6 desaturase message is significantly increased in strain L5LUD40R (LEU2 erg11⌬::URA3). The actin probe was used as a control to quantitate relative amounts of mRNA in each lane.
(erg3⌬::LEU2) and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3). Increased ERG3 message is present in the ERG11 deletion mutant L5LUD40R (LEU2 erg11⌬::URA3). On probing with the PCR fragment of the ERG11 ORF, no transcript is detected in the ERG11 deletion mutants, L5LUD40R (LEU2 erg11⌬::URA3) and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3). Markedly increased amounts of ERG11 transcript are detected in the ERG3 deletion mutant L5D (erg3⌬::LEU2) (Fig. 7) . L5 (leu2) RNA and serial dilutions of L5LUD40R (LEU2 erg11⌬::URA3) and L5D (erg3⌬::URA3) RNA were probed with the ERG3 gene and the ERG11 gene, respectively, again by using the actin gene as a control. These studies revealed a Ͼ20-fold increase in the amount of ERG3 message in L5LUD40R (LEU2 erg11⌬::URA3) and the amount of ERG11 message in L5D (erg3⌬::LEU2) in comparison with L5 (leu2) message (data not shown).
Sterol analysis. The sterol profiles of strains L5 (leu2), L5D (erg3⌬::LEU2), L5LUD40R (LEU2 erg11⌬::URA3), and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) are shown in Table 3 . Ergosterol was the major sterol detected in the parent C. glabrata strains L5 (leu2) and L5L (LEU2), in common with other wild-type yeasts and fungi. However, it was replaced mainly by ergosta-7,22-dien-3␤-ol in strain L5D (erg3⌬::LEU2), consistent with the deletion of ERG3, which encodes ⌬ 5,6 sterol desaturase. Sterol analysis was not carried out on strain L5LUD40 (ERG11, encoding P-450 DM , deleted) because it is viable only in anaerobic medium supplemented with ergosterol. We reasoned that under these conditions, the sterol profile would reflect mainly exogenously supplied ergosterol rather than sterols synthesized de novo. Furthermore, exogenous ergosterol could influence the synthesis and composition of endogenous sterols, as might the absence of P-450 DM activity, thereby precluding a meaningful interpretation of the data. However, sterol analysis was carried out on strain L5LUD40R (LEU2 erg11⌬::URA3), a spontaneous mutant derived from L5LUD40 (LEU2 erg11⌬::URA3). Unlike L5 (leu2) and L5L (LEU2), which contained mainly ergosterol, L5LUD40R (LEU2 erg11⌬::URA3) biosynthesized the 14␣-methylated sterols, lanosterol, obtusifoliol, and 4,14␣-dimethylzymosterol. By contrast, the sterol fraction of the double mutant, L5DUD61 (ERG3 and ERG11 deleted), consisted of mainly 14␣-methylfecosterol, with smaller amounts of lanosterol, obtusifoliol, and 4,14␣-dimethylzymosterol.
Antifungal susceptibility. The results of antifungal susceptibility testing are shown in Table 4 . Strain L5D (erg3⌬::LEU2) remained susceptible to azole and polyene antifungal agents. Strains L5LUD40R (LEU2 erg11⌬::URA3) and L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) were resistant to the highest concentrations of azole antifungal agents tested and showed a twoto threefold increase in resistance to amphotericin B.
Generation times. The generation times at 30ЊC were as follows. Strains L5 (leu2) and L5L (LEU2), which accumulate mostly ergosterol, had generation times of 1.21 and 1.24 h, respectively. L5D (erg3⌬::LEU2), whose sterol fraction consisted of mostly ergosta-7,22-dien-3␤-ol, had a generation time of 1.76 h. L5LUD40R (LEU2 erg11⌬::URA3), which contains 
DISCUSSION
While mutations in the S. cerevisiae ERG3 gene have been shown to be associated with azole resistance (34) and lack of ⌬ 5,6 desaturase activity is associated with azole resistance in C. albicans (14) , we have not shown a similar effect following disruption of the ERG3 gene in C. glabrata L5 (leu2). These data reveal differences in the development of azole resistance between these closely related yeast species. It has been postulated that the S. cerevisiae ERG3 gene may also play a role in azole resistance by exerting a suppressor effect on otherwise lethal mutations of the ERG11 gene, which encodes P-450 DM , the target enzyme of azole antifungal agents (4, 27, 33) . We have demonstrated the same protective result of the presence of a defective ERG3 gene in C. glabrata L5DUD61 (erg3 ⌬::LEU2 erg11⌬::URA3), in which the ERG11 gene was disrupted following disruption of the ERG3 gene. This strain is aerobically viable, accumulates 14␣-methylfecosterol, and is resistant to azole antifungal agents. In contrast, following the disruption of the ERG11 gene in strain L5L (LEU2), which has a functional ERG3 gene, L5LUD (LEU2 erg11⌬::URA3) strains required ergosterol and anaerobic conditions for growth. However, our studies also show that another mechanism unrelated to mutation or disruption of the ERG3 gene allows C. glabrata to overcome the lethal effect of an ERG11 gene disruption. L5LUD40R (LEU2 erg11⌬::URA3), an aerobically viable strain arising spontaneously from C. glabrata L5LUD (LEU2 erg11⌬::URA3), did not have a defective ERG3 gene as determined by DNA sequence analysis and Northern blot analysis. Aerobically viable strains have also been spontaneously recovered from S. cerevisiae erg11 mutants, but these strains have been shown to harbor mutations in the ERG3 gene (4, 27, 34) .
The C. glabrata strains with disrupted ERG11 genes, L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) and L5LUD40R (LEU2 erg11⌬::URA3), were resistant to azole antifungal agents and also showed increased resistance to the polyene antifungal agent amphotericin B. The resistance to azole antifungal agents is not surprising, since ERG11 encodes the target enzyme of these agents. The increased amphotericin B resistance of these mutants is less striking: a two-to threefold increase was observed in comparison with resistances of the parent strains L5 (leu2), L5L (LEU2), and L5D (erg3⌬::LEU2). This difference, although small, may be of clinical significance and suggests that strains defective in removal of the C-14 methyl group are less suitable targets for this membrane-active agent than are strains with functional P-450 DM activity. This finding is in agreement with studies of C. albicans 6.4, which is resistant to both azole and polyene antifungal agents and accumulates only C-14-methylated sterols (11) .
As in S. cerevisiae, disruption of the ERG3 gene in C. glabrata results in the accumulation of ergosta-7,22-dien-3␤-ol. C. albicans strains postulated to harbor mutations in the ERG3 gene have been shown to accumulate either ergosta-7,22-dien-3␤-ol (25, 26) or fecosterol (14) as their major sterol. Accumulation of the latter sterol suggests that desaturation of the ⌬ 5,6 bond may be required for activity of ⌬ 8,7 isomerase, ⌬ 22 desaturase, or ⌬ 24 (28) reductase. The difference in sterol composition between C. albicans ⌬ 5,6 desaturase mutants may therefore reflect strain-to-strain variation or defects in sterol biosynthesis genes in addition to those encoding ⌬ 5,6 sterol desaturase.
As in S. cerevisiae, sequential disruption of the ERG3 and ERG11 genes in C. glabrata produced a mutant which accumulates primarily 14␣-methylfecosterol. Bard et al. (4) have demonstrated, by constructing strains with null mutations in both ERG3 and ERG11 genes, that S. cerevisiae does not require C-14-demethylated sterols for aerobic growth. We have shown that this is also the case with C. glabrata L5DUD61 (erg3⌬::LEU2 erg11⌬::URA3) and L5LUD40R (LEU2 erg11 ⌬::URA3).
The 14␣-methylated sterol fraction of L5LUD40R (LEU2 erg11⌬::URA3) contained mainly lanosterol and smaller amounts of obtusifoliol and 4,14-dimethylzymosterol. This indicates that, as with S. cerevisiae, lanosterol appears to be the preferred substrate for the P-450 DM of C. glabrata. However, Aoyama and Yoshida (1), using P-450 DM purified from S. cerevisiae, have shown that the enzyme is equally active on 24-methylenedihydrolanosterol. The 14␣-methylated sterol fractions of C. albicans and filamentous fungi contain primarily 24-methylenedihydrolanosterol (11, 21, 30) . Hitchcock et al. (12) purified the C. albicans P-450 DM and found that the enzyme was 10-to 20-fold less active than that of S. cerevisiae when tested in a model membrane system with lanosterol as the substrate. One possible explanation given for this result was that the preferred substrate of C. albicans enzyme may be 24-methylenedihydrolanosterol. Further studies are needed to definitively identify the natural substrate of the C. glabrata P-450 DM .
We have demonstrated a marked increase in the amount of ERG11 transcript in L5D (erg3⌬::LEU2). A similar increase in the amount of ERG3 transcript was seen to occur in L5LUD40R (LEU2 erg11⌬::URA3) following deletion of the ERG11 gene. These data suggest that ergosterol plays a role in the regulation of genes involved in its biosynthesis through a negative-feedback mechanism. Turi and Loper (28) have shown that S. cerevisiae ERG11 message levels are increased during growth in glucose, in the presence of heme, and during both oxygen-limited and anaerobic growth conditions. Activity of P-450 DM requires the presence of oxygen, and the increased levels of ERG11 message seen under anaerobic growth conditions may have resulted from the production of 14␣-methylated sterols which were unable to function as suppressors of ERG11 transcription.
Construction of mutants with null mutations of genes involved in the biosynthesis of ergosterol and analysis of their sterol profiles provide important information regarding the biosynthesis of ergosterol in pathogenic yeast species. This information should prove useful in determining the mechanism(s) of resistance in clinical isolates. The use of sterol profiles alone and the interpretation of results obtained from Northern analysis are not sensitive tools in defining the genetic defects which lead to the development of resistance in pathogenic fungi.
